UroCompanion
← All procedures
Kidney SurgeryLast updated 1 May 2026

Robotic Partial Nephrectomy

kidneyoncologynephron-sparing

Overview

Robotic partial nephrectomy is the standard nephron-sparing operation for cT1 renal masses when technically feasible. Equivalent oncologic outcomes to radical nephrectomy, with preserved renal function and lower long-term cardiovascular morbidity. Transperitoneal approach is the most common; retroperitoneal is an option for posterior tumours and prior abdominal surgery.

Indications

  • cT1 (≤7 cm) renal mass when partial is technically feasible.
  • Imperative indications: solitary kidney, bilateral tumours, baseline CKD, familial RCC syndromes.
  • Selected cT2 disease in expert hands.

Contraindications

  • Tumour anatomy that precludes safe partial resection with negative margins.
  • Tumour thrombus extending into renal vein or IVC.
  • Severely compromised performance status precluding pneumoperitoneum.

Anatomy

  • Retroperitoneal kidney within Gerota's fascia.
  • Renal hilum, anterior to posterior: vein, artery, pelvis.
  • Anterior relationships: liver (right) or spleen/pancreas (left), and bowel.
  • Posterior segmental artery typically posterior to the upper pole.

Steps

  1. Positioning: modified lateral decubitus, flank up, table flexed. Arms padded, axillary roll.
  2. Port placement: standard four-arm robotic configuration. Camera at umbilicus or just lateral, working ports along the lateral abdomen, assistant port in the midline.
  3. Colon mobilisation: incise along the white line of Toldt and reflect colon medially.
  4. Expose Gerota's fascia: identify ureter and gonadal vessels as landmarks; lift the kidney anteriorly.
  5. Hilar dissection: identify renal artery and vein. Skeletonise the artery for clamping.
  6. Intraoperative ultrasound: confirm tumour location and margins, score capsule with cautery.
  7. Hilar clamp: bulldog on the artery (selective if feasible). Start ischaemia clock.
  8. Tumour excision: cold scissors, take a thin rim of normal parenchyma, orient the specimen.
  9. Renorrhaphy: inner running V-Loc closure of collecting system / medulla. Outer sliding-clip or running closure of parenchyma over a haemostatic bolster.
  10. Unclamp: confirm haemostasis. Place haemostatic agents as needed.
  11. Specimen retrieval: in a retrieval bag through the assistant port.
  12. Closure: extract specimen, close fascia, skin.

Operative Pearls

  • Minimise warm ischaemia time; aim for <25 min. Off-clamp or selective clamping where anatomy allows.
  • Score the capsule before clamping — saves ischaemia time.
  • Tumour orientation for pathology before the specimen leaves the field.
  • Close collecting system entries under direct vision; methylene blue down the ureteric stent if available helps confirm.
  • Selective arterial clamping (super-selective with vessel loops or robotic bulldogs) preserves perfusion to unaffected parenchyma.

Complications

  • Haemorrhage (intraoperative or delayed pseudoaneurysm)
  • Urine leak
  • Positive surgical margin (low incidence with adequate technique)
  • Acute kidney injury
  • Conversion to open or radical nephrectomy

Outcomes

  • Equivalent oncologic outcomes to radical nephrectomy for cT1 disease.
  • Better preservation of eGFR at 1 and 5 years.
  • Lower long-term cardiovascular events compared to radical.

References

  • AUA Renal Mass and Localized Renal Cancer Guideline (2021, amended 2023)
  • EAU Guidelines on Renal Cell Carcinoma (2025)

Key Exam Points

  • Preferred approach for cT1 (≤7 cm) renal masses when technically feasible — oncologically equivalent to radical with better renal function preservation.
  • Equivalent oncologic outcomes to radical nephrectomy for cT1 disease.
  • Better preservation of eGFR at 1 and 5 years compared to radical nephrectomy.
  • Lower long-term cardiovascular events compared to radical nephrectomy.
  • Warm ischaemia time should be kept under 25 minutes when possible to preserve renal function.
  • Positive surgical margin rate is low with adequate technique; intraoperative frozen section is not routinely needed.
  • Key complications: bleeding, urine leak, positive margin, AKI, conversion to open or radical.
  • Aligned with AUA Renal Mass and Localized Renal Cancer Guideline (2021, amended 2023) and EAU Guidelines on RCC (2025).